Clinical Trial Update: PS-002 for the Treatment of IgA Nephropathy in Adults [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates PS-002 for immunoglobulin A nephropathy is in Phase 1/Phase 2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• PS-002

Snippet

Sponsor: Purespring Therapeutics Limited | Conditions: Immunoglobulin A (IgA) Nephropathy | Phase 1, Phase 2 | Status: RECRUITING